by Lewis Cantley
Click on the enzyme names or on the the arrows to follow the PIP pathway.
Please download the Adobe Flash Player to view this content:
Following the PI 3-kinase pathway
Related Cell Signaling content:
Remodeling the Model T
var FO = { movie:"http://images.the-scientist.com/supplementary/flash/53942/pip.swf", width:"520", height:"780", majorversion:"8", build:"0", xi:"true"}; UFO.create(FO, "ufoDemo"); Putting the P in PIP by Lewis Cantley Click on the enzyme names or on the the arrows to follow the PIP pathway. Please download the Adobe Flash Player to view this content: Related Articles From Kinase to Cancer Following the PI 3-kinase
by Lewis Cantley
Click on the enzyme names or on the the arrows to follow the PIP pathway.
Please download the Adobe Flash Player to view this content:
Following the PI 3-kinase pathway
Related Cell Signaling content:
Remodeling the Model T


These fluttering sensations are the brain’s reaction to certain emotions, which can be amplified or soothed by the gut’s own “bugs".
View this Issue
Olga Anczukow and Ryan Englander discuss how transcriptome splicing affects immune system function in lung cancer.


In our next roundtable webinar, learn how scientists leverage spatial biology to map tissues, uncover cellular interactions, and advance disease research.

Discover how scientists use the latest gene editing tools to advance health research.


Fujirebio's Lumipulse® G pTau217/β-Amyloid 1-42 Plasma Ratio test has the potential to shorten the Alzheimer's disease diagnostic journey and enable earlier intervention through its accessibility and high diagnostic performance.


Ten-year Agreement to Provide a Secure, AI-enabled Forensic Laboratory Information Management System Supporting DHS Forensic, Scientific, and Testing Services

deliver robust, reproducible solutions for sample preparation enabling a new era of end-to-end standardization in proteomics

Enables higher-throughput, cost effective single-cell sequencing

Enables ultra-low variant detection across a range of key MRD targets in AML, including very large FLT3-ITDs